  Opening Symposium |
|
Sunday, August 31 (2:30 p.m.- 4:00 p.m.)
Room I
 |
Night time control of acid secretion:
a challenge for a new PPI in acid-related diseases
|
| |
Chairpersons:
D.O.
Castell (Charleston,
USA) M.
Hongo (Sendai,
Japan)
|
- |
Acid suppression in Barrett's esophagus: now or never ? |
| |
J.P. GALMICHE (Nantes)
|
-
|
24-hour gastric pH monitoring in acid-related disorders
|
|
|
|
-
|
Nocturnal acid breakthrough management and clinical importance
|
|
|
P.O. KATZ (Philadelphia)
|
-
|
Experimental and clinical pharmacology of tenatoprazole, a novel Proton Pump Inhibitor
|
|
|
C. SCARPIGNATO (Parma)
|
|
| S1 |
Monday, September 1 (10:30 a.m.- 12:30 a.m.)
Room I
|
Endoscopic mucosal ablation or resection for Barrett’s esophagus: possibilities and limitations
|
| |
Chairman: Ph. Monnier (Lausanne)
|
-
|
Mucosal ablation: is it necessary?
|
|
|
T.R. DeMEESTER (Los Angeles)
|
-
|
Photodynamic therapy for mucosal ablation of BE |
|
|
K.K. WANG (Rochester, MN)
|
-
|
Circumferential endoscopic mucosal resection of the distal esophagus and cardia: techniques and outcomes |
|
|
H. INOUE (Tokyo)
|
-
|
Endoscopic mucosal resection: unresolved problems for eradication of BE
|
|
|
|
- |
Laparoscopic trans-gastric esophageal mucosal resection for high-grade-dysplasia |
| |
C.T. FRANTZIDES (Chicago)
|
-
|
A new rigid resectoscope for endoscopic mucosal ablation. |
|
|
Ph. MONNIER (Lausanne)
|
-
|
Panel discussion |
|
| S2 |
Monday,
September 1 (1:30 - 3:15 p.m.)
Room IV
|
The
tools for detection of duodenal juice in the stomach
|
| |
Chairman:
P. Bechi (Florence)
|
- |
Opening preliminary comments
|
|
P. Bechi (Florence)
|
- |
Bilitec 2000: what does it actually measure?
|
|
F. Baldini (Florence)
|
- |
Bilitec monitoring, an aid in identification of patients at risk for
mucosal injury .
|
|
T.R. DeMeester (Los Angeles)
|
- |
Clinical usefulness of Bilitec in the esophagus |
| |
J.E. RICHERT (Cleveland)
|
- |
Clinical usefulness of Bilitec in the stomach |
|
H.J. Stein (Munich)
|
- |
Effects of vagotomy, pyloroplasty and prokinetic therapy on gastric exposure to bile. |
|
J.M. Collard (Brussels)
|
- |
Association of duodeno-gastric and duodeno-esophageal reflux |
|
M. Fein (Wurzburg)
|
- |
In vivo reliability of Bilitec for detection of bile in the gastric lumen
|
|
|
- |
Discussion and closing remarks
|
| |
| S2' |
Monday, September 1 (3:30 - 5:30 p.m.)
Room IV
|
New York City GERD Network Symposium
|
Chairman: C.J. Lightdale (New York)
|
- |
Introduction and background |
|
C.J. LIGHTDALE (New York) |
- |
Corporate partnership |
|
T. PHELAN (New York) - J.H. LEE (New York) |
- |
Research Programs |
|
L. COHEN (New York) |
- |
Educational Programs |
|
C.J. LIGHTDALE (New York) |
- |
Round table discussion
|
| S3 |
Monday,
September 1 (1:30 - 3:15
p.m.)
Room II
|
New
techniques of investigation for Barrett’s esophagus
|
| |
|
-
|
Endoscopic diagnosis: state of the art and vision
for the future
|
|
|
T.
PONCHON (Lyons)
|
-
|
Functional
endoscopy: new information available |
|
|
I.
HERMANN (Roma)
|
-
|
Wireless esophageal
pHmetry: direct comparison with the standard probe
|
|
|
F.
MION (Lyons)
|
-
|
Photodiagnosis
by autofluorescence in Barrett esophagus |
|
|
G.
BOURG-HECKLY (Paris)
|
|
| S4 |
Tuesday, September 2 (8:30 a.m. - 10:15 a.m.)
Room IV
|
In vitro and in vivo models for Barrett's esophagus and esophageal carcinoma (1)
|
| |
Chairpersons: J.W. Harmon (Baltimore) -H.S. Garewal (Tucson)
|
-
|
The relationship of esophagitis to esophageal motility dysfunction in a feline model
|
|
|
P. BIANCANI (Providence)
|
-
|
Lessons from animal models of esophageal carcinogenesis : the status prior to the OESO Conference
|
|
|
P. BONDE (Belfast)
|
-
|
An E1A/E1B transgenic mouse model of gastro-esophageal carcinogenesis |
|
|
M.
DUNCAN (Baltimore)
|
-
|
The sequential model of Barrett's esophagus and adenocarcinoma induced by
duodeno-esophageal reflux without exogenous carcinogens |
| |
K.MIWA (Kanazawa)
|
- |
Cancer induction by duodeno-gastro-esophageal reflux alone? |
| |
M. FEIN (Würzburg)
|
| |
|
|
| S5 |
Tuesday, September 2 (10:30 a.m. - 1:00 p.m.)
Room IV
|
In vitro and in vivo models for Barrett's esophagus and esophageal carcinoma (2)
|
| |
Chairpersons: J.W. Harmon (Baltimore) -H.S. Garewal (Tucson)
|
-
|
The spectrum of pathologic findings in rat models of reflux-induced esophageal injury
|
|
|
E. MONTGOMERY (Baltimore)
|
-
|
Chemoprevention
of esophageal adenocarcinoma by COX-2 inhibitors
in an animal model of Barrett's
esophagus |
|
|
N. BUTTAR (Rochester, MN)
|
-
|
Studies with the esophago-gastro-duodenal anastomosis model of esophageal adenocarcinoma: roles of oxidative stress and aberrant arachidonic acid metabolism in carcinogenesis.
|
|
|
L.X. CHEN (Piscataway, NJ)
|
-
|
Effect of free radicals and antioxidants in a rat experimental model of intestinal metaplasia and carcinoma of the esophagus; |
|
|
A. ESCARTIN (Zaragoza)
|
|
| S6 |
Tuesday,
September 2 (2:00 p.m. - 4:00 p.m.)
Room IV
|
Bile
acids and their effects on esophageal epithelium
|
| |
Chairman: H.S. Garewal (Tucson)
|
-
|
Bile acids, inflammatory cytokines and apoptosis
|
|
|
K. DVORAKOVA (Tucson)
|
-
|
Bile acid acid activation of
the mitogen-activated protein kinase pathways in Barrett's esophagus |
|
|
R. SOUZA (Dallas)
|
-
|
Effect of proton pump inhibitors on esophageal microenvironment
including bile acids |
|
|
P. ATHERFOLD (Leicester)
|
|
| S7 |
Tuesday,
September 2 (4:10 p.m. - 5:45 p.m.)
Room II
|
Place
of hiatal prostheses in surgery of the esophageal hiatus
|
|
Chairpersons:
B. Gayet (Paris)
- C. T. Frantzides (Chicago)
|
-
|
Long-term results of laparoscopic repair of large hiatal hernias
|
| |
T.R. DeMeester (Los Angeles)
|
-
|
Value of hiatal prosthesis in surgical repair
|
| |
B. GAYET (Paris)
|
-
|
Circumferential prostheses - Video
|
| |
Th. PERNICENI (Paris)
|
-
|
Shoe horse prostheses - Video
|
| |
J.G. BALIQUE (St Etienne)
|
-
|
The use of mesh prosthesis for hiatal hernia repair
|
| |
C.T. FRANTZIDES (Chicago)
|
- |
Quality of life and results after laparoscopic anti-reflux surgery
in patients with hiatal mesh prosthesis |
| |
F.A. GRANDERATH (Zell-am-See) |
|
| S8 |
Wednesday,
September 3 (8:30 a.m. - 10:35 a.m.)
Room IV
|
New
endoscopic treatments for GERD and Barrett's esophagus disease.
|
|
Chairman: G.N.J. Tytgat (Amsterdam)
|
-
|
Wide spread mucosal resection
|
|
|
|
-
|
Endoscopic gastroplasty (Endocinch)
|
| |
|
- |
A new device for totally endoluminal stapled anterior fundoplication |
| |
A.R. SHAPIRA (Omer)
|
-
|
New plication devices
|
| |
|
- |
Radiofrequency ablation
|
| |
J. TACK (Leuven)
|
- |
Endoscopic implantation (Enteryx) |
| |
L. COHEN (New york)
|
- |
Gatekeeper
|
| |
P. FOCKENS (Amsterdam)
|
- |
New endoscopic apparatus for resection of Barrett's
mucosa
|
| |
L. BONAVINA (Milan)
|
- |
Discussion and closing remarks. |
| |
|
|
| S9 |
Wednesday,
September 3 (11:00 a.m. - 1:05 p.m.)
Room IV
|
Pathology Symposium
|
|
Chairpersons:
H.D. Appelman (Ann Arbor) – G.
Chejfec (Chicago)
|
-
|
What the hell is dysplasia?
|
|
|
H.D. APPELMAN (Ann Arbor)
|
-
|
Has a histologic transition
from GERD-damaged epithelium to columnar metaplasia ever been
seen in human subjects?
|
|
|
|
-
|
What is he histologic sequence
of changes that have been proven to occur in the transition from
Barrett mucosa to carcinoma?
|
|
|
G. CHEJFEC (Chicago)
|
-
|
Is there any way for pathologists
to decrease interobserver variability in the diagnosis of dysplasia?
|
|
|
E. MONTGOMERY (Baltimore)
|
-
|
Is adenocarcinoma of the
EG junction or cardia different from Barrett adenocarcinoma?
|
|
|
N. ECTORS (Leuven)
|
-
|
Is there
a set of histologic changes that are invariably reflux-associated?
|
| |
K. TAKUBO (Tokyo)
|
-
|
What is the role of cytokeratins
in Barrett/cardia differentiation
|
|
|
M. YOUNES (Huston, USA)
|
-
|
Do 40% of patients resected
for Barrett's High Grade Dysplasia
have an unsuspected adenocarcinoma?
|
|
|
R. GENTA - E.R. TSCHANZ (Geneva)
|
|
ISDE Symposium
|
Monday,
September 1 (8:00 a.m. - 10:10 a.m.)
Room II
|
Barrett
esophagus
|
|
Chairpersons: T.R. DeMeester (Los Angeles) – S.J. Spechler (Dallas)
|
- |
What is the best evidence that:
|
|
Best surgical treatment causes regression
|
| |
P. PARRILLA (Murcia)
|
- |
What is the best evidence that
|
|
Best medical treatment causes regression
|
|
G. TRIADAFILOPOULOS (Palo-Alto)
|
- |
Optimal management of high-grade dysplasia:
|
|
Endoscopic surveillance.
|
|
|
S.J. SONTAG (Hines - IL)
|
|
Cox-2
|
|
K.K. WANG(Rochester - MN)
|
|
Endoluminal ablation
|
|
|
Ch. ELL (Wiesbaden)
|
|
Resection
|
|
|
M.K. FERGUSON (Chicago)
|
- |
Molecular biology perspectives
|
|
|
J. JANKOWSKI (Leicester)
|
- |
Recommendations
|
|
|
S.J. SPECHLER (Dallas)
T.R. DeMEESTER (Los Angeles) |
| W1 |
Tuesday,
September 2 (8:30 a.m. - 10:15 a.m.)
Room II
|
Surgical
Workshop (1): Training and Simulation
|
-
|
Introduction
to Training and Simulation: Thomas BÜRGER, (ESI)
|
-
|
Teaching surgeons:
R. PEYTON (Dungannon)
|
-
|
GI
Mentor / SIMBIONIX : Th. PONCHON (Lyons)
|
-
|
Transfer
of skills from training to Operating Room : T.
GALLAGHER (Atlanta)
|
-
|
Panel
discussion
|
-
|
Hands
on
|
|
| W2 |
Tuesday,
September 2 (10:30 a.m. - 12:00
p.m.)
Room II
|
Surgical
Workshop (2): Diagnostic and navigation
|
-
|
Introduction:
Th BERLAGE (Sankt Augustin)
|
-
|
Hi
resolution MRI and CT / R. SEIBEL (Dortmund)
|
-
|
Navigation
systems / BIOSENSE WEBSTER
|
-
|
Augmented
reality / FRAUNOFER INSTITUTE
|
-
|
Panel
discussion
|
|
| W3 |
Tuesday,
September 2 (12:00 p.m. - 1:00 p.m.)
Room II
|
Surgical
Workshop (3): Robotics and Operating Room Integrating
Systems
|
-
|
Introduction:
J. KUKLETA (Zurich)
|
-
|
DaVinci
/ INTUITIVE SURGICAL
|
-
|
Hermes
/ COMPUTER MOTION
|
-
|
Operating
Room 1 / STORZ
|
-
|
Hands
on
|
|
| W4 |
Tuesday,
September 2 (2:00 p.m. - 4:00 p.m.)
Room II
|
Surgical
Workshop (4): Robotics and Operating Room Integrating
Systems (cont)
|
-
|
Actual
possibilities in robotic technology: E. COSTES - MANIERE
|
-
|
Suturing
with a robot: P. GIULIANOTTI (School
of Robotic Surgery, Grosseto)
|
-
|
Esophagectomy
with robotic assistance (video) : G.B. CADIÈRE (Brussels)
|
-
|
Panel
discussion
|
-
|
Hands
on
|
-
|
Robotics in digestive
surgery: the next revolution? B. GAYET (Paris) |
|
|
|
